Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.850
-0.018 (-2.03%)
At close: Dec 2, 2024, 4:00 PM
0.824
-0.025 (-3.00%)
Pre-market: Dec 3, 2024, 4:38 AM EST

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $3.39M in the quarter ending September 30, 2024, a decrease of -11.55%. This brings the company's revenue in the last twelve months to $20.27M, up 41.13% year-over-year. In the year 2023, Carisma Therapeutics had annual revenue of $14.92M with 51.71% growth.

Revenue (ttm)
$20.27M
Revenue Growth
+41.13%
P/S Ratio
1.72
Revenue / Employee
$189,421
Employees
107
Market Cap
35.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.92M5.09M51.71%
Dec 31, 20229.83M--
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.